268 related articles for article (PubMed ID: 36482996)
1. Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy.
Feng B; Lu Y; Ye L; Yin L; Zhou Y; Chen A
Front Endocrinol (Lausanne); 2022; 13():1043174. PubMed ID: 36482996
[TBL] [Abstract][Full Text] [Related]
2. Separating the effects of life course adiposity on diabetic nephropathy: a comprehensive multivariable Mendelian randomization study.
Zhang H; Zhang Q; Song Y; Wang L; Cai M; Bao J; Yu Q
Front Endocrinol (Lausanne); 2024; 15():1285872. PubMed ID: 38390197
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study.
Lu J; Liu X; Jiang S; Kan S; An Y; Zheng C; Li X; Liu Z; Xie G
J Clin Endocrinol Metab; 2022 May; 107(6):1599-1608. PubMed ID: 35191949
[TBL] [Abstract][Full Text] [Related]
4. A Mendelian randomization study on causal effects of 25(OH) vitamin D levels on diabetic nephropathy.
He M; Yang T; Zhou P; Bu P; Yang X; Zou Y; Zhong A
BMC Nephrol; 2023 Jun; 24(1):192. PubMed ID: 37369991
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Dejenie TA; Abebe EC; Mengstie MA; Seid MA; Gebeyehu NA; Adella GA; Kassie GA; Gebrekidan AY; Gesese MM; Tegegne KD; Anley DT; Feleke SF; Zemene MA; Dessie AM; Moges N; Kebede YS; Bantie B; Adugna DG
Front Endocrinol (Lausanne); 2023; 14():1124367. PubMed ID: 37082121
[TBL] [Abstract][Full Text] [Related]
6. A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy.
Deng P; Li Z; Yi B; Leng Y
Front Endocrinol (Lausanne); 2022; 13():1000627. PubMed ID: 36589806
[TBL] [Abstract][Full Text] [Related]
7. Causality between sarcopenia and diabetic nephropathy: a bidirectional Mendelian randomization study.
Ren L; Wang Y; Ju F; Sun M; Gang X; Wang G
Front Endocrinol (Lausanne); 2023; 14():1188972. PubMed ID: 37284212
[TBL] [Abstract][Full Text] [Related]
8. Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.
Yan S; Wang H; Feng B; Ye L; Chen A
Front Immunol; 2024; 15():1332757. PubMed ID: 38533501
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy Among Patients with Diabetes Mellitus: a Meta-Analysis.
Zhou B; Zou H; Xu G
Kidney Blood Press Res; 2016; 41(6):919-928. PubMed ID: 27889768
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Glucose/C-Peptide Ratio and the Risk of Disease Progression in Diabetic Nephropathy Patients: A Clinical Retrospective Analysis.
Tong H; Wang D; Fang M
J Healthc Eng; 2022; 2022():7406764. PubMed ID: 35399828
[TBL] [Abstract][Full Text] [Related]
11. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
Fan C; Gao Y; Sun Y
Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
[TBL] [Abstract][Full Text] [Related]
12. Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study.
Lin CC; Li CI; Liu CS; Liao LN; Yang CW; Lin CH; Yang SY; Li TC
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36828641
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
14. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
Ahola AJ; Sandholm N; Forsblom C; Harjutsalo V; Dahlström E; Groop PH;
Kidney Int; 2017 May; 91(5):1178-1185. PubMed ID: 28238338
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.
van der Laan SW; Fall T; Soumaré A; Teumer A; Sedaghat S; Baumert J; Zabaneh D; van Setten J; Isgum I; Galesloot TE; Arpegård J; Amouyel P; Trompet S; Waldenberger M; Dörr M; Magnusson PK; Giedraitis V; Larsson A; Morris AP; Felix JF; Morrison AC; Franceschini N; Bis JC; Kavousi M; O'Donnell C; Drenos F; Tragante V; Munroe PB; Malik R; Dichgans M; Worrall BB; Erdmann J; Nelson CP; Samani NJ; Schunkert H; Marchini J; Patel RS; Hingorani AD; Lind L; Pedersen NL; de Graaf J; Kiemeney LA; Baumeister SE; Franco OH; Hofman A; Uitterlinden AG; Koenig W; Meisinger C; Peters A; Thorand B; Jukema JW; Eriksen BO; Toft I; Wilsgaard T; Onland-Moret NC; van der Schouw YT; Debette S; Kumari M; Svensson P; van der Harst P; Kivimaki M; Keating BJ; Sattar N; Dehghan A; Reiner AP; Ingelsson E; den Ruijter HM; de Bakker PI; Pasterkamp G; Ärnlöv J; Holmes MV; Asselbergs FW
J Am Coll Cardiol; 2016 Aug; 68(9):934-45. PubMed ID: 27561768
[TBL] [Abstract][Full Text] [Related]
16. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
[TBL] [Abstract][Full Text] [Related]
17. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
18. The Causal Effect of Systolic Blood Pressure Lowering on Vascular Outcomes in Diabetes: A Mendelian Randomization Study.
Hou T; Li M; Lin H; Zhao Z; Lu J; Wang T; Xu Y; Wang W; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2022 Aug; 107(9):2616-2625. PubMed ID: 35703944
[TBL] [Abstract][Full Text] [Related]
19. Causality of Diabetic Nephropathy and Age-Related Macular Degeneration: A Mendelian Randomization Study.
Chen X; Chen L; Lin Y; Li G
Gene; 2023 Dec; 889():147787. PubMed ID: 37689221
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study.
Zhang Y; Tang Z; Tong L; Wang Y; Li L
Front Endocrinol (Lausanne); 2023; 14():1277984. PubMed ID: 38034019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
